Iveda Solutions, Inc. filings document the company's public-company reporting as a Delaware corporation focused on AI video surveillance, smart city technologies, and IoT platforms. Registration statements and amendments describe securities offerings, capital structure, operating and financial results, and risk disclosures tied to the company's technology business.
Current reports cover material events including Nasdaq continued-listing notices, stockholders' equity compliance, minimum bid-price matters, and registered securities consisting of common stock and common stock purchase warrants. Proxy materials document annual meeting matters such as director elections, auditor ratification, shareholder voting mechanics, and governance procedures.
Iveda Solutions, Inc. has been notified by Nasdaq that its common stock no longer meets the exchange’s minimum bid price requirement of $1 per share, after trading below that level for 30 consecutive business days. The notice does not immediately affect the stock’s Nasdaq listing.
The company has 180 calendar days, until September 2, 2026, to regain compliance. Nasdaq will deem the requirement met if the closing bid price is at least $1 for a minimum of ten consecutive business days during this period. If compliance is not restored or other listing rules are breached, Nasdaq may move to delist the shares, although Iveda could appeal any delisting determination to a Nasdaq Hearings Panel.
Iveda Solutions director Robert Gillen reported offsetting option transactions tied to an option repricing. He was granted 100,000 stock options on an "acquire" transaction and disposed of 100,000 options back to the issuer on a separate "disposition to issuer" transaction, leaving 128,599 options reported as held afterward.
According to a board-approved repricing on February 23, 2026, his options were reset to an exercise price of $0.29 per share while all other terms remained unchanged. The company states these transactions were exempt under Rule 16b-6(d) and Rule 16b-3 of the Exchange Act.
Iveda Solutions Chief Financial Officer Robert J. Brilon reported changes to his stock options in a paired, non-cash transaction. He was granted 125,000 options and disposed of 125,000 options, both recorded as “Options (Right to Buy).” Following these transactions, he holds 152,503 derivative securities directly.
The company’s board approved an option repricing on February 23, 2026, resetting the exercise price of his options to $0.29 per share. The filing states that all other option terms remain unchanged and that the repricing was exempt under specific Exchange Act rules.
Iveda Solutions director Franco Alejandro reported an option repricing and related award. On February 23, 2026, the board approved a repricing of his options to an exercise price of $0.29 per share, with all other terms unchanged. This involved an acquisition of 25,000 options and a corresponding disposition of 25,000 options to the issuer, both recorded at a transaction price of $0.00 per option. Following these transactions, Alejandro directly held 53,130 options to acquire Iveda Solutions stock. The company notes these transactions were exempt under Rule 16b-6(d) and Rule 16b-3 of the Exchange Act.
Iveda Solutions, Inc. reported that Chief Executive Officer David H. Ly had his stock options repriced by the board. On February 23, 2026, options covering 175,000 shares were granted or awarded, and a separate 175,000-option position was disposed of back to the issuer. According to the disclosure, the repricing set the exercise price at $0.29 per share, while all other option terms remained unchanged. After these offsetting derivative transactions, Ly directly held options to acquire 216,096 shares.
Iveda Solutions director Joseph A. Farnsworth reported option transactions tied to an option repricing. On February 23, 2026, he acquired 100,000 stock options at an exercise price of $0.29 per share and disposed of 100,000 options back to the company, with other option terms remaining unchanged.
Iveda Solutions reporting persons Lind Global Fund III LP, Lind Global Partners III LLC and Jeff Easton disclose beneficial ownership of 1,158,920 shares, representing 9.99% of common stock as of 02/11/2026. The holdings consist of 857,143 shares of common stock and 1,714,286 warrants, but conversion of the warrants is contractually limited so the aggregate beneficial ownership has been capped at 1,158,920 shares.
The filing states that Lind Global Partners III LLC may be deemed to have sole voting and dispositive power for the partnership's shares and that Jeff Easton, as managing member, may be deemed to have sole voting and dispositive power. The filing includes a joint filing agreement and is signed on 02/19/2026.
Iveda Solutions, Inc. received a Schedule 13G reporting a significant but non-controlling position by Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC. As of the close of business on February 13, 2026, they may be deemed to beneficially own 592,195 shares of common stock issuable upon exercise of a warrant, representing about 4.99% of the outstanding common stock.
The filing explains that additional shares underlying several Intracoastal warrants are blocked from exercise if doing so would push ownership above limits of 4.99% or 9.99%. The reporting persons certify the securities were not acquired to change or influence control of Iveda.
Iveda Solutions, Inc. completed a public offering of 5,714,286 shares of common stock (or pre-funded warrants in lieu) and Series X warrants to purchase up to 11,428,572 shares at a combined price of $0.35. The transaction generated approximately $2 million in gross proceeds before fees and expenses. The company issued additional placement agent warrants and paid cash fees to H.C. Wainwright & Co. and plans to use the net proceeds for general corporate purposes, including potential R&D, debt repayment, working capital, capital spending, acquisitions, joint ventures, and stock repurchase programs. The offering was conducted under an effective Form S-1 registration statement.
Iveda Solutions, Inc. received an institutional ownership filing showing that entities affiliated with Iroquois Capital report meaningful positions in its common stock. Iroquois Capital Management LLC reports beneficial ownership of 500,000 shares, representing 4.5% of the common stock, with shared voting and dispositive power over these shares.
Richard Abbe reports beneficial ownership of 714,286 shares, or 6.4% of the class, combining 214,286 shares over which he has sole voting and dispositive power with 500,000 shares over which he shares authority. Kimberly Page reports beneficial ownership of 500,000 shares, or 4.5%, with shared voting and dispositive power.
The filing notes additional warrants held by related entities that are exercisable for up to 1,000,000 and 428,572 shares for certain funds, and 1,428,572 shares for Mr. Abbe, but these are currently blocked by 4.99% Beneficial Ownership Blockers. Based on a prospectus indicating 11,139,740 shares outstanding as of the completion of a recent offering, the reported percentages reflect these blockers. The reporting persons certify that the securities are not held for the purpose of changing or influencing control of Iveda Solutions.